Page last updated: 2024-08-17

medroxyprogesterone acetate and African Lymphoma

medroxyprogesterone acetate has been researched along with African Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banda, K; Bunce, CM; Drayson, MT; Dunn, JA; Iqbal, G; Khanim, FL; Merrick, B; Molyneux, E1
Bunce, CM; Desmond, JC; Drayson, MT; Fenton, SL; Gordon, J; Luong, QT; Mustard, KJ; Pound, J; Sarafeim, A1

Trials

1 trial(s) available for medroxyprogesterone acetate and African Lymphoma

ArticleYear
Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).
    British journal of haematology, 2014, Volume: 164, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Burkitt Lymphoma; Child; Child, Preschool; Drug Resistance, Neoplasm; Endemic Diseases; Female; Humans; Malawi; Male; Medroxyprogesterone Acetate; Recurrence

2014

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and African Lymphoma

ArticleYear
Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease.
    Leukemia, 2003, Volume: 17, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Apoptosis; bcl-X Protein; Burkitt Lymphoma; Cell Division; Clofibric Acid; Drug Interactions; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Medroxyprogesterone Acetate; Proto-Oncogene Proteins c-bcl-2; Transduction, Genetic; Tumor Cells, Cultured

2003